2013. An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients with Advanced Metastatic Prostate Cancer -. Journal of Cancer Research Updates. 2, 1 (Jan. 2013),  21–25. DOI:https://doi.org/10.6000/1929-2279.2013.02.01.4.